SmithKline Beecham Kytril
Executive Summary
Granisetron tablet indication expanded July 27 to include prevention of nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. Kytril is currently indicated for the prevention of nausea and vomiting associated with emetogenic cancer therapies, including high dose cisplatin